Greater male than female variability in regional brain structure across the lifespan by Wierenga, L.M. et al.
R E S E A R CH A R T I C L E
Greater male than female variability in regional brain structure
across the lifespan
Lara MWierenga1,2 | Gaelle E Doucet3,4 | Danai Dima5,6 | Ingrid Agartz7,8,9 |
Moji Aghajani10,11,12 | Theophilus N Akudjedu13,14 | Anton Albajes-Eizagirre15,16,17 |
Dag Alnæs7,18 | Kathryn I Alpert19 | Ole A Andreassen7,18 | Alan Anticevic20 |
Philip Asherson21 | Tobias Banaschewski22 | Nuria Bargallo23,24 |
Sarah Baumeister22 | Ramona Baur-Streubel25 | Alessandro Bertolino26 |
Aurora Bonvino26 | Dorret I Boomsma27 | Stefan Borgwardt28,29 |
Josiane Bourque30,31 | Anouk den Braber27,32 | Daniel Brandeis22,33,34,35 |
Alan Breier36 | Henry Brodaty37,38 | Rachel M Brouwer39 | Jan K Buitelaar40,41 |
Geraldo F Busatto42 | Vince D Calhoun43 | Erick J Canales-Rodríguez15,16 |
Dara M Cannon13 | Xavier Caseras44 | Francisco X Castellanos45,46 |
Tiffany M Chaim-Avancini42 | Christopher RK Ching47 | Vincent P Clark48,49 |
Patricia J Conrod31,50 | Annette Conzelmann51,52 | Fabrice Crivello53 |
Christopher G Davey54,55 | Erin W Dickie56,57 | Stefan Ehrlich58 |
Dennis van't Ent27 | Simon E Fisher59,60 | Jean-Paul Fouche61 |
Barbara Franke60,62,63 | Paola Fuentes-Claramonte15,16 | Eco JC de Geus27 |
Annabella Di Giorgio64 | David C Glahn65,66 | Ian H Gotlib67 |
Hans J Grabe68,69 | Oliver Gruber70 | Patricia Gruner20 | Raquel E Gur30,71 |
Ruben C Gur30 | Tiril P Gurholt7,18 | Lieuwe de Haan72 | Beathe Haatveit7,18 |
Ben J Harrison73 | Catharina A Hartman74 | Sean N Hatton75,76 |
Dirk J Heslenfeld77 | Odile A van den Heuvel10,78 | Ian B Hickie75 |
Pieter J Hoekstra79 | Sarah Hohmann22 | Avram J Holmes20,80,81 |
Martine Hoogman60,62 | Norbert Hosten82 | Fleur M Howells83,84 |
Hilleke E Hulshoff Pol39 | Chaim Huyser85,86 | Neda Jahanshad47 |
Anthony C James87,88 | Jiyang Jiang37 | Erik G Jönsson7,9 | John A Joska84 |
Andrew J Kalnin89 | Karolinska Schizophrenia Project (KaSP) Consortium |
Marieke Klein39,60,62 | Laura Koenders72 | Knut K Kolskår18,90,91 |
Bernd Krämer70 | Jonna Kuntsi21 | Jim Lagopoulos92,93 | Luisa Lazaro16,94,95,96 |
Irina S Lebedeva97 | Phil H Lee81,98 | Christine Lochner99 |
Marise WJ Machielsen100 | Sophie Maingault101 | Nicholas G Martin102 |
Received: 4 June 2020 Revised: 10 August 2020 Accepted: 5 September 2020
DOI: 10.1002/hbm.25204
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2020 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.
Hum Brain Mapp. 2020;1–30. wileyonlinelibrary.com/journal/hbm 1
Ignacio Martínez-Zalacaín103,104 | David Mataix-Cols9 | Bernard Mazoyer105,106 |
Brenna C McDonald107 | Colm McDonald13 | Andrew MMcIntosh108 |
Katie L McMahon109,110 | Genevieve McPhilemy13 | Dennis van der Meer7,18,111 |
José M Menchón16,103,104 | Jilly Naaijen40 | Lars Nyberg112,113 |
Jaap Oosterlaan114,115 | Yannis Paloyelis6 | Paul Pauli116,117 |
Giulio Pergola26,118 | Edith Pomarol-Clotet15,16 | Maria J Portella16,119 |
Joaquim Radua9,15,16,17,120 | Andreas Reif121 | Geneviève Richard7,18 |
Joshua L Roffman122 | Pedro GP Rosa42 | Matthew D Sacchet123 |
Perminder S Sachdev37,124 | Raymond Salvador15,16 | Salvador Sarró15,16 |
Theodore D Satterthwaite30 | Andrew J Saykin107,125 | Mauricio H Serpa42 |
Kang Sim126,127 | Andrew Simmons128 | Jordan W Smoller81,129 |
Iris E Sommer130 | Carles Soriano-Mas16,103,131 | Dan J Stein132 |
Lachlan T Strike133 | Philip R Szeszko3,134 | Henk S Temmingh84 |
Sophia I Thomopoulos47 | Alexander S Tomyshev97 | Julian N Trollor37 |
Anne Uhlmann84,135 | Ilya M Veer136 | Dick J Veltman137 | Aristotle Voineskos56 |
Henry Völzke138,139,140 | Henrik Walter136 | Lei Wang19 | Yang Wang141 |
Bernd Weber142 | Wei Wen37 | John D West107 | Lars T Westlye7,18,90 |
Heather C Whalley108,143 | Steven CR Williams144 | Katharina Wittfeld68,69 |
Daniel H Wolf30 | Margaret J Wright133,145 | Yuliya N Yoncheva146 |
Marcus V Zanetti42,147 | Georg C Ziegler148 | Greig I de Zubicaray110 |
Paul M Thompson47 | Eveline A Crone1,2,149 | Sophia Frangou3,150 |
Christian K Tamnes7,8,151
1Institute of Psychology, Leiden University, Leiden, The Netherlands
2Leiden Institute for Brain and Cognition, Leiden, The Netherlands
3Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York
4Boys Town National Research Hospital, Omaha, Nebraska
5Department of Psychology, School of Arts and Social Sciences, City, University of London, London, UK
6Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
7Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo,
Norway
8Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
9Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Stockholm County Council,
Stockholm, Sweden
10Department of Psychiatry, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands
11Department of Research & Innovation, GGZ inGeest, Amsterdam, The Netherlands
12Institute of Education and Child Studies, Forensic Family and Youth Care, Leiden University, Leiden, The Netherlands
13Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing
and Health Sciences, National University of Ireland Galway, Galway, Ireland
14Institute of Medical Imaging & Visualisation, Faculty of Health & Social Sciences, Bournemouth University, Bournemouth, UK
15FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain
16Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain
17Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2 WIERENGA ET AL.
18Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
19Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois
20Department of Psychiatry, Yale University, New Haven, Connecticut
21Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
22Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, University of Heidelberg, Medical Faculty Mannheim,
Mannheim, Germany
23Imaging Diagnostic Center, Hospital Clínic, Barcelona, Spain
24Magnetic Resonance Image Core Facility, IDIBAPS, Barcelona, Spain
25Department for Clinical Psychology, Würzburg University, Margetshöchheim, Germany
26Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy
27Department of Biological Psychology, VU University Amsterdam, Amsterdam, The Netherlands
28Department of Psychiatry, University of Basel, Basel, Switzerland
29Department of Psychiatry, University of Lübeck, Lübeck, Germany
30Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania
31CHU Sainte-Justine Research Center, Montreal, Quebec, Canada
32Alzheimer Center, Amsterdam UMC, Location VUMC, Amsterdam, The Netherlands
33Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
34Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
35Neuroscience Centre Zurich, University and ETH Zurich, Zurich, Switzerland
36Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana
37Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia
38Dementia Centre for Research Collaboration, School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia
39Department of Psychiatry, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands
40Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands
41Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands
42Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade
de S~ao Paulo, S~ao Paulo, Brazil
43Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State, Georgia Tech, Atlanta, Georgia
44MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK
45Department of Child and Adolescent Psychiatry, NYU Grossman School of Medicine, New York, New York
46Nathan Kline Institute for Psychiatric Research, Orangeburg, New York
47Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles,
California
48Psychology Clinical Neuroscience Center, Department of Psychology, University of New Mexico, Albuquerque, New Mexico
49Mind Research Network, Albuquerque, New Mexico
50Department of Psychiatry, University of Montreal, Montreal, Canada
51Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Tübingen, Tübingen, Germany
52Department of Psychology (Clinical Psychology II), PFH – Private University of Applied Sciences, Göttingen, Germany
53Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, Bordeaux, France
54Centre for Youth Mental Health, University of Melbourne, Parkville, Victoria, Australia
55Orygen, Parkville, Victoria, Australia
56Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Canada
57Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
58Division of Psychological & Social Medicine and Developmental Neurosciences; Technische Universität Dresden, Faculty of Medicine, University Hospital C.G.
Carus, Dresden, Germany
59Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands
60Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands
61Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, Western Cape, South Africa
62Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands
63Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands
WIERENGA ET AL. 3
64IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
65Tommy Fuss Center for Neuropsychiatric Disease Research, Department of Psychiatry, Boston Children's Hospital and Harvard Medical School, Boston,
Massachusetts
66Olin Center for Neuropsychiatric Research, Institute of Living, Hartford Hospital, Hartford, Connecticut
67Department of Psychology, Stanford University, Stanford, California
68Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany
69German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany
70Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University Hospital, Heidelberg, Germany
71Lifespan Brain Institute, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
72Department of Early Psychosis, Amsterdam UMC, Amsterdam, The Netherlands
73Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Australia
74Interdisciplinary Center Psychopathology and Emotion regulation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
75Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia
76Department of Neurosciences, University of California San Diego, La Jolla, California
77Departments of Experimental and Clinical Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
78Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
79Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
80Department of Psychology, Yale University, New Haven, Connecticut
81Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts
82Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany
83Neuroscience Institute, University of Cape Town, Cape Town, Western Cape, South Africa
84Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, Western Cape, South Africa
85De Bascule, Academic center child and adolescent psychiatry, Duivendrecht, The Netherlands
86Amsterdam UMC Department of Child and Adolescent Psychiatry, Amsterdam, The Netherlands
87Department of Psychiatry, Warneford Hospital, Oxford, UK
88Highfield Unit, Warneford Hospital, Oxford, UK
89Department of Radiology, The Ohio State University College of Medicine, Columbus, Ohio
90Department of Psychology, University of Oslo, Oslo, Norway
91Sunnaas Rehabilitation Hospital HT, Nesodden, Norway
92Sunshine Coast Mind and Neuroscience Thompson Institute, Birtinya, Queensland, Australia
93University of the Sunshine Coast, Sunshine Coast, Queensland, Australia
94Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic, Barcelona, Spain
95August Pi i Sunyer Biomedical Research Institut (IDIBAPS), Barcelona, Spain
96Department of Medicine, University of Barcelona, Barcelona, Spain
97Laboratory of Neuroimaging and Multimodal Analysis, Mental Health Research Center, Moscow, Russia
98Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
99SA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, Stellenbosch University, Cape Town, Western Cape, South Africa
100Department of Psychiatry, Academic Medical Center, Amsterdam, The Netherlands
101Institut des maladies neurodégénératives, Université de Bordeaux, Bordeaux, France
102Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
103Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain
104Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
105University of Bordeaux, Bordeaux, France
106Bordeaux University Hospital, Bordeaux, France
107Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana
108Division of Psychiatry, University of Edinburgh, Edinburgh, UK
109Herston Imaging Research Facility and School of Clinical Sciences, Queensland University of Technology (QUT), Brisbane, Queensland, Australia
110Faculty of Health, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Brisbane, Queensland, Australia
111School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
4 WIERENGA ET AL.
112Department of Radiation Sciences, Umeå University, Umeå, Sweden
113Department of Integrative Medical Biology, Umeå University, Umeå, Sweden
114Emma Children's Hospital, Amsterdam UMC University of Amsterdam and Vrije Universiteit Amsterdam, Emma Neuroscience Group, Department of Pediatrics,
Amsterdam Reproduction & Development, Amsterdam, The Netherlands
115Clinical Neuropsychology Section, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
116Department of Psychology, University of Würzburg, Würzburg, Germany
117Centre of Mental Health, Medical Faculty, University of Würzburg, Würzburg, Germany
118Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Mary Land
119Department of Psychiatry, Institut d'Investigació Biomèdica Sant Pau, Barcelona, Spain
120Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's
College London, London, UK
121Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfur am Maint, Germany
122Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts
123Center for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, Massachusetts
124Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick, New South Wales, Australia
125Indiana Alzheimer Disease Center, Indianapolis, Indiana
126West Region, Institute of Mental Health, Singapore, Singapore
127Yong Loo Lin School of Medicine, National University of Singapore, Singapore
128Department of Neuroimaging, Institute of Psychiatry, Psychology and Neurology, King's College London, London, UK
129Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts
130Department of Biomedical Sciences of Cells and Systems, Rijksuniversiteit Groningen, University Medical Center Groningen, Groningen, The Netherlands
131Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Barcelona, Spain
132SAMRC Unit on Risk & Resilience in Mental Disorders, Dept of Psychiatry & Neuroscience Institute, University of Cape Town, Cape Town, Western Cape, South
Africa
133Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
134Mental Illness Research, Education and Clinical Center (MIRECC), James J. Peters VA Medical Center, New York, New York
135Department of Child and Adolescent Psychiatry and Psychotherapy, Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany
136Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu
Berlin, and Berlin Institute of Health, Berlin, Germany
137Department of Psychiatry & Amsterdam Neuroscience, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands
138Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
139DZHK (German Centre for Cardiovascular Research), partner site Greifswald, Greifswald, Germany
140DZD (German Center for Diabetes Research), partner site Greifswald, Greifswald, Germany
141Department of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin
142Institute for Experimental Epileptology and Cognition Research, University Hospital Bonn, Bonn, Germany
143Division of Psychiatry, Royal Edinburgh Hospital, Edinburgh, UK
144Department of Neuroimaging, King's College London, London, UK
145Centre for Advanced Imaging, University of Queensland, Brisbane, Queensland, Australia
146Department of Child and Adolescent Psychiatry, NYU Child Study Center, Hassenfeld Children's Hospital at NYU Langone, New York, New York,
147Instituto de Ensino e Pesquisa, Hospital Sírio-Libanês, S~ao Paulo, Brazil
148Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany
149Department of Psychology, Education and Child Studies (DPECS), Erasmus School of Social and Behavioral Sciences, Erasmus University Rotterdam, The
Netherlands
150Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada
151PROMENTA Research Center, Department of Psychology, University of Oslo, Oslo, Norway
Correspondence
Lara M. Wierenga, Leiden University, Leiden,
The Netherlands.
Email: l.m.wierenga@fsw.leidenuniv.nl
Abstract
For many traits, males show greater variability than females, with possible implica-
tions for understanding sex differences in health and disease. Here, the ENIGMA
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(Enhancing Neuro Imaging Genetics through Meta-Analysis) Consortium presents the
largest-ever mega-analysis of sex differences in variability of brain structure, based
on international data spanning nine decades of life. Subcortical volumes, cortical sur-
face area and cortical thickness were assessed in MRI data of 16,683 healthy individ-
uals 1-90 years old (47% females). We observed significant patterns of greater male
than female between-subject variance for all subcortical volumetric measures, all cor-
tical surface area measures, and 60% of cortical thickness measures. This pattern was
stable across the lifespan for 50% of the subcortical structures, 70% of the regional
area measures, and nearly all regions for thickness. Our findings that these sex differ-
ences are present in childhood implicate early life genetic or gene-environment inter-
action mechanisms. The findings highlight the importance of individual differences
within the sexes, that may underpin sex-specific vulnerability to disorders.
1 | INTRODUCTION
For a diverse set of human traits and behaviors, males are often reported
to show greater variability than females (Hyde 2014). This sex difference
has been noted for aspects of personality (Borkenau, McCrae, and Ter-
racciano 2013), cognitive abilities (Arden and Plomin 2006; Johnson,
Carothers, and Deary 2008; Roalf et al. 2014), and school achievement
(Baye and Monseur 2016). A fundamental question is to what degree
these sex differences are related to genetic mechanisms or social factors,
or their interactions. Lehre et al. (2009) found compelling evidence for
an early genetic or in utero contribution, reporting greater male variabil-
ity in anthropometric traits (e.g. body weight and height, blood parame-
ters) already detectable at birth. Recent studies suggest greater male
variability also in brain structure and its development (Forde et al. 2020;
Ritchie et al. 2018; Wierenga et al. 2018, 2019), but studies with larger
samples that cover both early childhood and old age are critically
needed. Specifically, we do not know when sex differences in variability
in brain structure emerge and whether they change with development
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and throughout life. Yet, data on this could inform us on the origins and
factors that influence this phenomenon. For this reason, we set out to
analyze magnetic resonance imaging (MRI) data from a large sample
of individuals across a very wide age range (n = 16,683, age 1-90) to
robustly characterize sex differences in variability of brain structure
and test how these differences interact with age.
Many prior studies report sex differences in brain structure, but
the specificity, regional pattern and functional relevance of such
effects are not clear (Herting et al. 2018; Koolschijn and Crone 2013;
Marwha, Halari, and Eliot 2017; Ruigrok et al. 2014; Tan et al. 2016).
One reason could be that most studies have examined mean differ-
ences between the sexes, while sex differences in variability remain
understudied (Del Giudice et al. 2016; Joel et al. 2015). As mean and
variance measure two different aspects of the distribution (center and
spread), knowledge on variance effects may provide important insights
into sex differences in the brain. Recent studies observed greater male
variance for subcortical volumes and for cortical surface area to a
larger extent than for cortical thickness (Ritchie et al. 2018; Wierenga
et al. 2018, 2019). However, further studies are needed to explore
regional patterns of variance differences, and, critically, to test how
sex differences in variability in the brain unfold across the lifespan.
An important question pertains to the mechanisms involved in
sex differences in variability. It is hypothesized that the lack of two
parental X-chromosomal copies in human males may directly relate to
greater variability and vulnerability to developmental disorders in
males compared to females (Arnold 2012). All cells in males express
an X-linked variant, while female brain tissues show two variants. In
females, one of the X-chromosomes is randomly silenced, as such
neighboring cells may have different X related genetic expression
(Wu et al. 2014). Consequently, one could expect that in addition to
greater variability across the population, interregional anatomical cor-
relations may be stronger in male relative to female brains. This was
indeed observed for a number of regional brain volumes in children
and adolescents, showing greater within-subject homogeneity across
regions in males than females (Wierenga et al. 2018). These results
remain to be replicated in larger samples as they may provide clues
about mechanisms and risk factors in neurodevelopmental disorders
(e.g. attention-deficit/hyperactivity disorder and autism spectrum dis-
order) that show sex differences in prevalence (Bao and Swaab 2010),
age of onset, heritability rates (Costello et al. 2003), or severity of
symptoms and course (Goldstein, Seidman, and O'brien 2002).
In the present study, we performed mega-analyses on data from
the enhancing neuroimaging genetics through meta-analysis (ENIGMA)
Lifespan working group (Dima et al., 2020; Frangou et al., 2020;
Jahanshad and Thompson 2016). A mega-analysis allows for analyses of
data from multiple sites with a single statistical model that fits all data
and simultaneously accounting for the effect of site. Successfully pooling
lifespan data was recently shown in a study combining 18 datasets to
derive age trends of brain structure (Pomponio et al. 2020). This con-
trasts with meta-analysis where summary statistics are combined and
weighted from data that is analyzed at each site (van Erp et al. 2019).
MRI data from a large sample (n = 16,683) of participants aged 1 to
90 years was included. We investigated subcortical volumes and regional
cortical surface area and thickness. Our first aim was to replicate previ-
ous findings of greater male variability in brain structure in a substantially
larger sample. Based on prior studies (Forde et al. 2020; Ritchie
et al. 2018; Wierenga et al. 2018, 2019) and reports of somewhat
greater genetic effect on surface area than thickness (Eyler et al. 2011;
Kremen et al. 2013), we hypothesized that greater male variance would
be more pronounced for subcortical volumes and cortical surface area
than for cortical thickness, and that greater male variance would be
observed at both upper and lower ends of the distribution. Our second
aim was to test whether observed sex differences in variability of brain
structure are stable across the lifespan from birth until 90 years of age,
or e.g. increase with the accumulation of experiences (Pfefferbaum,
Sullivan, and Carmelli 2004). Third, in line with the single X-chromosome
hypothesis, we aimed to replicate whether males show greater inter-
regional anatomical correlations (i.e. within-subject homogeneity) across
brain regions that show greater male compared to female variance
(Wierenga et al. 2019).
2 | METHODS
2.1 | Participants
The datasets analyzed in the present study were from the Lifespan
working group within the ENIGMA Consortium (Jahanshad and
Thompson 2016). There were 78 independent samples with MRI data,
in total including 16,683 (7,966 males) healthy participants aged
1-90 years from diverse ethnic backgrounds (see detailed descriptions
at the cohort level in Table 1). Samples were drawn from the general
population or were healthy controls in clinical studies. Screening pro-
cedures and the eligibility criteria (e.g. head trauma, neurological his-
tory) may be found in Supplemental Table 1. Participants in each
cohort gave written informed consent at the local sites. Furthermore,
at each site local research ethics committees or Institutional Review
Boards gave approval for the data collection, and all local institutional
review boards permitted the use of extracted measures of the
completely anonymized data that were used in the present study.
2.2 | Imaging data acquisition and processing
For definition of all brain measures, whole-brain T1-weighted anatom-
ical scan were included. Detailed information on scanner model and
image acquisition parameters for each site can be found in Supple-
mental Table 1. T1 weighted scans were processed at the cohort level,
where subcortical segmentation and cortical parcellation were per-
formed by running the T1-weighted images in FreeSurfer using ver-
sions 4.1, 5.1, 5.3 or 6.0 (see Supplemental Table 1 for specifications
per site). This software suite is well validated and widely used, and
documented and freely available online (surfer.nmr.mgh.harvard.edu).
The technical details of the automated reconstruction scheme are
described elsewhere (Dale, Fischl, and Sereno 1999; Fischl et al. 1999,
2002). The outcome variables included volumes of seven subcortical
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TABLE 1 Sex distributions and age of subjects by sample
Sample Total N Sex N
Age
Mean SD Range
EDINBURGH 55 Male 20 23.9 2.5 18.5–28.4
Female 35 23.7 3.1 18.6–30.6
UNIBA 131 Male 67 30.3 10.0 18.0–63.0
Female 64 24.3 6.8 18.0–52.0
Tuebingen 50 Male 22 38.4 11.1 26.0–61.0
Female 28 42.2 12.5 24.0–61.0
GSP 2009 Male 894 27.8 16.8 18.0–90.0
Female 1115 26.7 16.2 18.0–89.0
Melbourne 102 Male 54 19.5 2.9 15.0–25.0
Female 48 19.6 3.1 15.0–26.0
HMS 55 Male 21 41.3 11.2 24.0–59.0
Female 34 38.5 12.8 19.0–64.0
ENIGMA-OCD (1) 66 Male 30 30.6 8.9 19.0–56.0
Female 36 35.1 10.9 18.0–61.0
NUIG 93 Male 54 34.1 11.6 18.0–57.0
Female 39 39.0 11.0 18.0–58.0
NeuroIMAGE 383 Male 177 16.8 3.6 7.7–28.5
Female 206 17.0 3.8 7.8–28.6
CAMH 141 Male 72 43.2 18.9 18.0–86.0
Female 69 44.1 19.8 18.0–82.0
Basel 44 Male 17 25.7 4.5 19.0–35.0
Female 27 25.3 4.2 19.0–39.0
Bordeaux 452 Male 220 26.9 7.8 18.0–57.0
Female 232 26.6 7.7 18.0–56.0
FBIRN 174 Male 124 37.6 11.3 19.0–60.0
Female 50 37.4 11.3 19.0–58.0
KaSP 32 Male 15 27.4 5.5 21.0–43.0
Female 17 27.6 5.9 20.0–37.0
CODE 72 Male 31 43.7 12.4 25.0–64.0
Female 41 36.6 13.4 20.0–63.0
Indiana (1) 49 Male 9 71.9 6.6 63.0–80.0
Female 40 60.4 11.6 37.0–84.0
COMPULS/TS EUROTRAIN 53 Male 36 10.8 1.0 8.7–12.9
Female 17 11.0 1.1 9.2–12.9
FIDMAG 123 Male 54 36.4 8.5 19.0–63.0
Female 69 38.4 11.2 19.0–64.0
NU 79 Male 46 31.6 14.5 14.6–66.3
Female 33 34.4 15.3 14.2–67.9
SHIP-TREND 818 Male 467 50.5 14.4 22.0–81.0
Female 351 49.6 14.0 21.0–81.0
SHIP-2 373 Male 207 55.6 12.8 31.0–84.0
Female 166 54.4 12.0 32.0–88.0
QTIM 340 Male 111 22.5 3.3 16.0–29.3
Female 229 22.7 3.4 16.1–30.0
Betula 287 Male 136 61.6 12.5 25.5–81.3
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TABLE 1 (Continued)
Sample Total N Sex N
Age
Mean SD Range
Female 151 64.1 13.1
TOP 303 Male 159 34.5 8.8 18.3–56.2
Female 144 36.3 10.9 19.3–73.4
HUBIN 102 Male 69 42.1 9.0 19.4–54.9
Female 33 41.7 8.5 19.9–56.2
StrokeMRI 52 Male 19 47.9 20.8 20.0–77.0
Female 33 43.6 23.0 18.0–78.0
AMC 99 Male 65 22.5 3.4 17.0–32.0
Female 34 23.6 3.3 18.0–29.0
NESDA 65 Male 23 40.7 9.7 23.0–56.0
Female 42 40.1 9.9 21.0–54.0
Barcelona (1) 30 Male 14 15.1 1.5 13.0–17.0
Female 16 14.9 2.1 11.0–17.0
Barcelona (2) 44 Male 24 14.4 1.8 11.0–17.0
Female 20 14.8 2.4 11.0–17.0
Stages-Dep 32 Male 9 46.6 8.4 37.0–58.0
Female 23 45.8 8.2 27.0–58.0
IMpACT 144 Male 57 34.2 11.0 19.0–62.0
Female 87 37.2 12.6 19.0–63.0
BIG 1319 Male 657 29.8 15.4 17.0–82.0
Female 662 26.9 12.9 13.0–79.0
IMH Stanford 56 Male 22 36.0 10.5 20.4–60.5
34 Female 34 37.5 10.8 18.9–56.3
MCIC (1) + (2) 93 Male 63 32.8 12.2 18.0–58.0
Female 30 32.5 11.9 19.0–60.0
OLIN 599 Male 237 36.3 13.3 22.0–86.5
Female 362 35.9 12.8 21.0–74.0
Neuroventure 137 Male 62 13.7 0.6 12.4–14.9
Female 75 13.6 0.7 12.3–14.9
CIAM 30 Male 16 27.1 5.9 19.0–40.0
Female 14 26.1 3.8 20.0–33.0
ENIGMA-HIV 31 Male 16 25.6 4.7 19.0–33.0
Female 15 23.9 4.1 20.0–32.0
Meth-CT 62 Female 13 26.1 4.1 19.0–34.0
Males 49 27.0 7.9 18.0–53.0
ENIGMA-OCD 26 Male 10 34.6 13.6 19.0–56.0
Female 16 28.8 7.8 20.0–46.0
Oxford 38 Male 18 16.5 1.6 14.1–18.9
Female 20 15.9 1.1 13.7–17.7
Yale 23 Male 12 14.4 2.4 10.3–17.5
Female 11 14.0 2.0 9.9–16.5
Sao Paulo-1 69 Male 45 27.1 5.6 18.0–42.0
Female 24 27.5 6.4 17.0–43.0
Sao Paulo-3 85 Male 45 28.2 7.3 18.0–43.0
Female 40 32.7 8.8 18.0–50.0
(Continues)
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TABLE 1 (Continued)
Sample Total N Sex N
Age
Mean SD Range
ENIGMA-OCD (2) 49 Male 19 32.1 7.8 24.0–53.0
Female 30 31.3 7.7 21.0–50.0
ENIGMA-OCD (3) 35 Male 16 42.9 12.9 22.5–64.0
Female 19 36.0 8.8 21.5–49.3
ENIGMA-OCD (4) 23 Male 9 13.1 2.9 8.8–15.9
Female 14 13.8 2.4 8.7–16.8
ENIGMA-OCD (5) 33 Male 12 30.7 8.8 21.0–53.0
Female 21 39.2 11.5 24.0–63.0
SYDNEY 157 Male 65 42.0 22.4 12.0–84.0
Female 92 37.1 21.7 13.0–78.0
IMH 79 Male 50 30.7 8.3 23.0–53.9
Female 29 34.2 12.4 20.4–59.0
UPENN 187 Male 86 35.7 12.9 18.0–71.0
Female 101 35.8 14.7 16.0–85.0
ADHD-NF 13 Male 7 13.3 1.2 11.9–14.8
Female 6 13.4 0.8 12.1–14.2
Indiana (2) 66 Male 26 40.2 15.3 19.0–65.0
Female 40 39.4 14.1 20.0–65.0
Sydney MAS 523 Male 236 78.3 4.6 70.3–89.8
Female 287 78.5 4.7 70.5–90.1
OADS (1) 118 Male 39 73.8 5.5 65.0–84.0
Female 79 70.4 5.6 65.0–84.0
Cardiff 318 Male 89 28.1 7.8 19.0–57.0
Female 229 24.2 7.0 18.0–58.0
CEG 32 Male 32 15.6 1.7 13.0–19.0
NYU 51 Male 31 30.2 7.7 18.8–46.0
Female 20 31.4 10.3 19.8–51.9
CLiNG 321 Male 131 25.5 5.4 19.0–58.0
Female 190 24.9 5.1 18.0–57.0
NTR (1) 112 Male 42 28.5 8.0 19.0–56.0
Female 70 37.0 10.5 19.0–57.0
NTR (2) 30 Male 11 28.4 3.6 22.0–33.0
Female 19 28.6 9.8 1.0–42.0
NTR (3) 37 Male 14 15.1 1.5 12.0–17.0
Female 23 14.5 1.4 11.0–18.0
Indiana (2) + (3) 201 Male 97 21.6 14.4 6.0–79.0
Female 104 33.0 22.8 7.0–87.0
BIG 1291 Male 553 25.1 9.3 18.0–71.0
Female 738 23.3 6.9 18.0–66.0
OADS (2) 35 Male 15 70.1 5.7 65.0–81.0
Female 20 67.4 3.8 65.0–78.0
OADS (3) 153 Male 59 70.3 4.2 65.0–81.0
Female 94 69.7 4.6 65.0–81.0
OADS (4) 108 Male 30 69.8 4.5 65.0–85.0
Female 78 70.1 4.9 65.0–89.0
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structures: accumbens, caudate, pallidum, putamen, amygdala, hippo-
campus, and thalamus (Fischl et al. 2002), and cortical surface area
and thickness measures (Dale et al. 1999; Fischl et al. 1999) of
68 regions of the cerebral cortex (Desikan-Killiany atlas) (Desikan
et al. 2006). Quality control was also implemented at the cohort level
following detailed protocols (http://enigma.ini.usc.edu/protocols/
imaging-protocols). The statistical analyses included 13,696 partici-
pants for subcortical volumes, 11,338 for surface area measures, and
12,533 participants for cortical thickness analysis.
2.3 | Statistical analysis
Statistical analyses were performed using R Statistical Software. The
complete scripts are available in the Appendix. In brief, we first adjusted
all brain structure variables for cohort, field strength and FreeSurfer
version effects. As age ranges differed for each cohort this was done in
two steps: initially, a linear model was used to account for cohort effects
and non-linear age effects, using a third-degree polynomial function.
Next, random forest regression modelling (Breiman 2001) was used to
additionally account for field strength and FreeSurfer version. See
Supplemental Figure 1 for adjusted values. This was implemented in the
R package randomForest, which can accommodate models with inter-
actions and non-linear effects.
2.4 | Mean differences
Mean sex differences in brain structure variables were tested using
t-tests (FDR corrected, see (Benjamini and Hochberg 1995)) and
effect sizes were estimated using Cohen's d-value. A negative effect
size indicates that the mean was higher in females, and a positive
effect size indicates it was higher in males. The brain structure vari-
ables were adjusted for age and covariates described above. Graphs
were created with R package ggseg (Mowinckel and Vidal-
Pineiro, 2019).
2.5 | Variance ratio
Variance differences between males and females were examined,
after accounting for age and other covariates as described above.
Fisher's variance ratio (VR) was estimated by dividing variance mea-
sures for males and females. VR was log transformed to account for
VR bias (Katzman and Alliger 1992; Lehre et al. 2009). Letting yi
denote the observed outcome for observation number i and y^i its
predicted outcome, the residuals were then formed:
ri = yi−y^i
The residual variance Varmales and Varfemales were computed sepa-
rately for males and females, and used to form the test statistic
T =Varmales=Varfemales
For each outcome, a permutation test of the hypothesis that the sex
specific standard deviations were equal, was performed. This was done by
random permutation of the sex variable among the residuals. Using β per-
mutations, the p-value for the k-th outcome measure was computed as
pk =
XB
b=1
I Tb > Tð Þ=B
where I(Tb ≥ T) is an indicator function that is 1 when Tb ≥ T, and
0 otherwise. Thus, the p-value is the proportion of permuted test sta-
tistics (Tb) that were greater than the observed value T of the test sta-
tistic above. Here B was set to 10,000. FDR corrected values are
reported as significant.
2.6 | Shift Function
To assess the nature of the variability difference between males and
females, shift functions were estimated for each brain measure that
showed significant variance differences between males and females using
quantile regression forests (Meinshausen 2006; Rousselet, Pernet, and
Wilcox 2017), implemented in the R package quantregForest (see
Wierenga et al. 2018) for a similar approach). First, as described above,
TABLE 1 (Continued)
Sample Total N Sex N
Age
Mean SD Range
MHRC 52 Male 52 22.3 2.9 16.1–27.6
BRAINSCALE 277 Male 146 10.1 1.5 9.0–15.0
Female 131 9.9 1.2 9.0–14.1
Leiden 611 Male 299 16.2 4.7 8.3–28.1
Female 312 16.9 4.9 8.4–28.9
IMAGEN 1964 Male 952 14.5 0.4 13.2–15.7
Female 1012 14.5 0.4 13.3–16.0
ENIGMA-HIV 175 Male 175 38.8 6.5 29.0–50.0
UMCU 172 Male 84 40.2 16.5 18.0–80.0
Female 88 39.2 17.9 18.0–84.0
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brain measures were accounted for site, age, field strength and FreeSurfer
version. Next, quantile distribution functions were estimated for males
and females separately after aligning the distribution means. Let q be a
probability between 0 and 1. The quantile function specifies the values at
which the volume of a brain measure will be at or below any given q. The
quantile function for males is given as Q(qj males) and for females as Q
(qjfemales). The quantile distance function is then defined as:
D qð Þ=Q qjmalesð Þ−Q qjfemalesð Þ
A bootstrap method was used to estimate the standard error of
the quantile difference functions, which was used to form approxi-
mate 95% confidence intervals. If the quantile distance function is a
straight-line parallel to the x axis, this indicates a stable difference
between the sexes across the distribution and thus no detectable dif-
ference in variability. A positive slope indicates greater male variance.
More specifically, this would indicate that the males with the largest
values have relatively larger values than females with the largest
values, and males with the smallest values are relatively smaller values
than the females with the smallest values. A negative slope of the
quantile distance function would indicate larger variability in females
at both ends of the distribution.
2.7 | Variance change with age
To study whether the sex differences in variance are stable across the
age range we used the residuals of the predicted outcome measure
and each individual i:
ri = j yi−y^i j
The absolute value of ri was then used in a regression model. It was
next explored whether there was a significant (FDR corrected) age by
sex interaction effect using a linear model 1 and quadratic model 2:
yi =Agei  sexi + errori model1ð Þ
yi =Age
2
i  sexi + errori model2ð Þ
2.8 | Anatomical correlation analysis
Inter-regional anatomical associations were assessed by defining the
correlation between two brain structures, after accounting for age
and other covariates as described above. Anatomical correlation
matrices were estimated as previously applied in several structural
MRI studies for males and females separately (see e.g. Baaré
et al. 2001; Lerch et al. 2006). Next, the anatomical correlation matrix
for females was subtracted from the anatomical correlation matrix for
males, yielding a difference matrix.
Thus, the Pearson correlation coefficient between any two
regions i and j was assessed for males and females separately. This
produced two group correlation matrices Mij and Fij where i, j, = 1, 2, .
…, N, where N is the number of brain regions.
Sex specific means and standard deviations were removed by per-
forming sex specific standardization. The significance of the differ-
ences between Mij and Fij was assessed by the difference in their
Fisher's z-transformed values, and p-values were computed using per-
mutations. Whether these significantly differed between the sexes
was tested using a Chi-square test.
3 | RESULTS
3.1 | Sex differences in mean and variance
All brain measures were adjusted for cohort, field strength, FreeSurfer
version and (non-linear) age. As a background analysis, we first
assessed whether brain structural measures showed mean differences
between males and females to align our findings to previous reports
(Figure 1, Table 2). All subcortical volumes were significantly larger in
males, with effect sizes (Cohen's d-values) ranging from 0.41 (left
accumbens) to 0.92 (right thalamus), and an average effect size of 0.7.
In follow-up analyses with total brain volume as an additional covari-
ate we found a similar pattern, although effect sizes were smaller
(Supplemental Table S2A). Also for cortical surface area, all regions
showed significantly larger values in males than females, with effect
sizes ranging from 0.42 (left caudal anterior cingulate area) to 0.97
(left superior temporal area), on average 0.71. When total surface area
was included as an additional covariate, a similar pattern was observed,
although effect sizes were smaller (Supplemental Table S2B). Cortical
thickness showed significant mean sex differences in 43 (out of 68)
regions, of which 38 regions showed larger thickness values in
females than males. These were mostly frontal and parietal regions.
The largest effect size, however, was only 0.12 (right caudal anterior
cingulate cortex). When total average cortical thickness was included
as an additional covariate, nine regions showed a male advantage that
was not observed in the raw data analysis, and six of the 38 regions
showing female advantage did not reach significance (Supplemental
Table S2C).
We then tested for sex differences in variance of brain structure,
adjusted for cohort, field strength, FreeSurfer version and (non-linear)
age (Figure 2, Tables 2). All subcortical volumes had significantly
greater variance in males than females. Log transformed variance
ratios ranged from 0.12 (right accumbens) to 0.36 (right pallidum),
indicating greater variance in males than females. Similar results were
also observed when total brain volume was taken into account (Sup-
plemental Table S2A). Cortical surface area also showed significantly
greater variance in males for all regions: variance ratios ranged from
0.13 (left caudal anterior cingulate cortex) to 0.36 (right para-
hippocampal cortex). This pattern was also observed when total sur-
face area was included in the model (Supplemental Table S2B).
Cortical thickness showed significantly greater male variance in
41 out of 68 regions, with the greatest variance ratio being 0.11 (left
precentral cortex). Notably, 37 of these 41 regions did not show
12 WIERENGA ET AL.
significantly larger mean thickness values in males. When additionally
accounting for total average thickness, we found greater male vari-
ance in 39 regions and greater females variance in 5 regions. Also
here, significant variance ratios were present in the absence of mean
sex differences (Supplemental Table S2C).
Next, we directly tested whether the regions showing larger vari-
ance effects were also those showing larger mean differences, by cor-
relating the variance ratios with the vector of d-values (Supplemental
Figure 2). There was a significant association for subcortical volumes
(r (12) = 0.7, p-value = .005), but no significant relation for regional
cortical surface area (r (66) = 0.18, p-value = .14), or thickness (r (66) =
-0.21, p-value = .09).
3.2 | Greater variance in males at upper and lower
tails
In order to characterise how the distributions of males and females
differ, quantiles were compared using a shift function (Rousselet
et al. 2017). As in the previous models, brain measures were adjusted
for cohort, field strength, FreeSurfer version and age. In addition, the
distribution means were aligned. Results showed greater male vari-
ance at both upper and lower tails for regions that showed significant
variance differences between males and females. The top three vari-
ance ratio effects for subcortical volume, cortical surface area and cor-
tical thickness are shown in Figure 3.
3.3 | Variance differences between sexes
across age
We next tested whether the sex differences in variance interacted
with age (Figure 4 and supplemental Figure 3). In this set of analyses,
brain measures were adjusted for cohort, field strength, and
FreeSurfer version. For 50% of the subcortical volume measures
there was a significant interaction, specifically for the bilateral thal-
ami, bilateral putamen, bilateral pallidum and the left hippocampus
(Table 3, Figure 5). Cortical surface area showed significant interac-
tion effects in 30% of the cortical regions (Table 3, Figure 5). In both
cases, younger individuals tended to show greater sex differences in
variance than older individuals. For cortical thickness, an interaction
with age was detected only in the left insula (Table 3, Figure 5). This
region showed greater male than female variance in the younger age
group, whereas greater female variance was observed in older
individuals.
Next, these analyses were repeated using a quadratic age model
(Supplemental Tables 3A-C). None of the subcortical or cortical sur-
face area measures showed quadratic age by sex interaction effects in
variance. Cortical thickness showed significant quadratic age by sex
effects in two regions; left superior frontal cortex and right lateral
orbitofrontal cortex.
3.4 | Sex differences in anatomical correlations
Finally, we tested whether females showed greater diversity than
males in anatomical correlations by comparing inter-regional anatomi-
cal associations between males and females. Using permutation test-
ing (B = 10000), the significance of correlation differences between
males and females was assessed.
Of the 91 subcortical-subcortical correlation coefficients, 2%
showed significantly stronger correlations in males, while, unexpect-
edly, 19% showed stronger correlations in females (tested two-sided)
(Figure 6A). A chi-square test of independence showed that this sig-
nificantly differed between males and females, X2 (1, N = 18)
= 10.889, p < .001. For surface area, no significant difference between
males and females were observed: significantly stronger male homo-
geneity was observed in 4% of the 2,278 unique anatomical correla-
tions, and similarly females also showed significantly stronger
correlations in 4% of the anatomical associations (Figure 6B). For
thickness, stronger male than female homogeneity was observed in
21% of the correlations, while stronger female correlations were
observed in <1% of the correlations (Figure 6C). This difference was
significant, X2 (1, N = 484) = 460.300, p < .001.
F IGURE 1 Sex differences in volumetric measures of subcortical volumes (left), cortical surface area (center), and cortical thickness (right).
Shown are effect sizes (Cohen's d-value) of FDR corrected mean sex differences. Greater mean values for males are displayed in blue, greater
mean values for females are displayed in red. Darker colors indicate larger effect sizes
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TABLE 2 Sex differences in mean and variance
(a) Subcortical volume Female (n = 7141) Male (n = 6555)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left thal -328.287 357.024 ** 0.840 0.237 **
Right thal -317.358 345.963 ** 0.918 0.357 **
Left caud -139.573 152.488 ** 0.609 0.150 **
Right caud -147.366 160.706 ** 0.625 0.147 **
Left put -237.405 257.178 ** 0.757 0.197 **
Right put -233.415 252.623 ** 0.786 0.220 **
Left pal -86.166 93.761 ** 0.768 0.317 **
Right pal -74.910 81.507 ** 0.793 0.339 **
Left hippo -137.976 149.409 ** 0.673 0.173 **
Right hippo -134.745 145.724 ** 0.669 0.232 **
Left amyg -73.754 80.305 ** 0.765 0.154 **
Right amyg -80.242 87.372 ** 0.790 0.216 **
Left accumb -22.255 24.369 ** 0.414 0.168 **
Right accumb -22.755 24.685 ** 0.454 0.119 **
(b) Surface area
Female (n = 6243) Male (n = 5092)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left bankssts -45.976 56.715 ** 0.596 0.282 **
Left caudalanteriorcingulate -25.875 31.956 ** 0.420 0.131 **
Left caudalmiddlefrontal -100.326 123.509 ** 0.589 0.163 **
Left cuneus -55.069 67.958 ** 0.605 0.188 **
Left entorhinal -19.379 23.824 ** 0.540 0.310 **
Left fusiform -142.081 174.977 ** 0.794 0.240 **
Left inferiorparietal -203.760 250.694 ** 0.751 0.288 **
Left inferiortemporal -158.709 195.821 ** 0.778 0.193 **
Left isthmuscingulate -54.544 67.228 ** 0.765 0.326 **
Left lateraloccipital -229.910 284.223 ** 0.893 0.240 **
Left lateralorbitofrontal -93.815 115.782 ** 0.771 0.194 **
Left lingual -114.132 141.130 ** 0.630 0.197 **
Left medialorbitofrontal -76.336 94.318 ** 0.741 0.288 **
Left middletemporal -139.909 172.666 ** 0.808 0.227 **
Left parahippocampal -24.273 30.139 ** 0.522 0.330 **
Left paracentral -46.588 57.790 ** 0.578 0.303 **
Left parsopercularis -63.862 78.461 ** 0.536 0.350 **
Left parsorbitalis -27.703 34.060 ** 0.755 0.223 **
Left parstriangularis -55.836 68.926 ** 0.633 0.262 **
Left pericalcarine -48.359 58.895 ** 0.485 0.151 **
Left postcentral -176.934 217.762 ** 0.867 0.286 **
Left posteriorcingulate -50.597 62.161 ** 0.651 0.253 **
Left precentral -207.652 255.826 ** 0.949 0.319 **
Left precuneus -163.276 200.728 ** 0.834 0.266 **
Left rostralanteriorcingulate -40.967 50.637 ** 0.619 0.160 **
Left rostralmiddlefrontal -297.267 365.653 ** 0.934 0.261 **
Left superiorfrontal -330.564 406.757 ** 0.962 0.269 **
Left superiorparietal -202.642 249.403 ** 0.730 0.241 **
Left superiortemporal -177.562 218.916 ** 0.970 0.262 **
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TABLE 2 (Continued)
(b) Surface area
Female (n = 6243) Male (n = 5092)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left supramarginal -205.547 254.230 ** 0.877 0.304 **
Left frontalpole -6.671 8.241 ** 0.439 0.249 **
Left temporalpole -15.185 18.664 ** 0.557 0.224 **
Left transversetemporal -19.898 24.463 ** 0.585 0.239 **
Left insula -84.765 104.782 ** 0.847 0.250 **
Right bankssts -42.654 52.655 ** 0.662 0.261 **
Right caudalanteriorcingulate -31.929 39.489 ** 0.465 0.275 **
Right caudalmiddlefrontal -95.924 117.705 ** 0.563 0.225 **
Right cuneus -61.606 75.541 ** 0.668 0.213 **
Right entorhinal -16.941 20.615 ** 0.467 0.339 **
Right fusiform -155.696 191.647 ** 0.900 0.225 **
Right inferiorparietal -278.411 342.870 ** 0.920 0.325 **
Right inferiortemporal -157.460 193.922 ** 0.827 0.187 **
Right isthmuscingulate -47.046 57.740 ** 0.723 0.314 **
Right lateraloccipital -227.765 282.023 ** 0.876 0.279 **
Right lateralorbitofrontal -99.594 122.823 ** 0.765 0.234 **
Right lingual -110.640 136.478 ** 0.644 0.225 **
Right medialorbitofrontal -70.180 86.695 ** 0.777 0.203 **
Right middletemporal -155.924 192.222 ** 0.857 0.224 **
Right parahippocampal -30.721 37.810 ** 0.708 0.357 **
Right paracentral -57.941 71.375 ** 0.609 0.349 **
Right parsopercularis -53.895 65.892 ** 0.506 0.312 **
Right parsorbitalis -35.086 43.159 ** 0.771 0.197 **
Right parstriangularis -69.557 85.138 ** 0.634 0.252 **
Right pericalcarine -56.327 68.894 ** 0.528 0.145 **
Right postcentral -168.595 208.307 ** 0.851 0.278 **
Right posteriorcingulate -52.836 65.327 ** 0.662 0.237 **
Right precentral -216.995 267.894 ** 0.950 0.341 **
Right precuneus -184.909 228.043 ** 0.878 0.248 **
Right rostralanteriorcingulate -33.179 41.005 ** 0.576 0.221 **
Right rostralmiddlefrontal -294.685 363.055 ** 0.898 0.228 **
Right superiorfrontal -325.198 400.002 ** 0.939 0.258 **
Right superiorparietal -205.624 252.962 ** 0.765 0.216 **
Right superiortemporal -132.506 163.787 ** 0.800 0.243 **
Right supramarginal -168.426 207.920 ** 0.754 0.285 **
Right frontalpole -9.712 11.996 ** 0.481 0.194 **
Right temporalpole -11.097 13.725 ** 0.422 0.228 **
Right transversetemporal -14.315 17.686 ** 0.564 0.194 **
Right insula -95.695 117.482 ** 0.863 0.238 **
(c) Thickness
Female (n = 6620) Male (n = 5913)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left bankssts 0.001 -0.001 n.s. 0.011 0.039 **
Left caudalanteriorcingulate 0.026 -0.028 ** 0.213 -0.042 n.s.
Left caudalmiddlefrontal 0.008 -0.008 ** 0.103 0.061 *
Left cuneus 0.000 0.000 n.s. 0.001 0.050 *
(Continues)
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TABLE 2 (Continued)
(c) Thickness
Female (n = 6620) Male (n = 5913)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left entorhinal -0.013 0.015 ** 0.084 0.023 n.s.
Left fusiform 0.001 -0.001 n.s. 0.016 0.022 n.s.
Left inferiorparietal 0.009 -0.009 ** 0.128 0.092 **
Left inferiortemporal -0.002 0.003 n.s. 0.027 0.004 n.s.
Left isthmuscingulate 0.009 -0.009 ** 0.088 -0.007 **
Left lateraloccipital 0.005 -0.005 ** 0.074 0.079 **
Left lateralorbitofrontal -0.002 0.003 n.s. 0.036 0.101 **
Left lingual -0.003 0.004 ** 0.058 0.040 n.s.
Left medialorbitofrontal -0.004 0.006 ** 0.058 0.027 n.s.
Left middletemporal -0.003 0.004 n.s. 0.037 0.093 *
Left parahippocampal 0.015 -0.016 ** 0.098 0.016 n.s.
Left paracentral 0.006 -0.005 ** 0.067 0.030 **
Left parsopercularis -0.002 0.003 n.s. 0.027 0.087 **
Left parsorbitalis 0.013 -0.014 ** 0.120 0.071 **
Left parstriangularis 0.004 -0.004 * 0.049 0.084 **
Left pericalcarine 0.000 0.001 n.s. 0.006 0.043 **
Left postcentral 0.008 -0.009 ** 0.133 0.078 **
Left posteriorcingulate 0.004 -0.004 ** 0.052 0.080 **
Left precentral 0.007 -0.007 ** 0.097 0.112 **
Left precuneus 0.000 0.000 n.s. 0.002 0.041 **
Left rostralanteriorcingulate 0.020 -0.021 ** 0.170 -0.046 n.s.
Left rostralmiddlefrontal 0.005 -0.004 ** 0.061 0.112 **
Left superiorfrontal 0.013 -0.014 ** 0.168 0.048 n.s.
Left superiorparietal 0.009 -0.009 ** 0.136 0.098 **
Left superiortemporal -0.001 0.001 n.s. 0.014 0.052 **
Left supramarginal 0.009 -0.009 ** 0.126 0.064 **
Left frontalpole 0.015 -0.016 ** 0.100 0.036 n.s.
Left temporalpole 0.004 -0.004 n.s. 0.023 0.027 n.s.
Left transversetemporal 0.020 -0.021 ** 0.177 0.018 n.s.
Left insula -0.009 0.011 ** 0.121 0.049 n.s.
Right bankssts -0.001 0.002 n.s. 0.016 0.064 **
Right caudalanteriorcingulate 0.027 -0.030 ** 0.242 -0.029 n.s.
Right caudalmiddlefrontal 0.008 -0.009 ** 0.109 0.019 **
Right cuneus 0.003 -0.002 n.s. 0.034 0.027 *
Right entorhinal 0.005 -0.005 n.s. 0.028 0.026 n.s.
Right fusiform 0.001 0.000 n.s. 0.008 0.029 n.s.
Right inferiorparietal 0.008 -0.008 ** 0.110 0.103 **
Right inferiortemporal 0.000 0.001 n.s. 0.003 0.032 n.s.
Right isthmuscingulate 0.010 -0.010 ** 0.099 -0.038 **
Right lateraloccipital 0.004 -0.004 ** 0.057 0.078 **
Right lateralorbitofrontal 0.003 -0.003 n.s. 0.036 0.074 **
Right lingual -0.002 0.003 n.s. 0.036 0.036 n.s.
Right medialorbitofrontal 0.003 -0.003 n.s. 0.033 0.056 n.s.
Right middletemporal -0.003 0.004 * 0.047 0.065 **
Right parahippocampal 0.021 -0.023 ** 0.162 0.028 n.s.
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4 | DISCUSSION
In this study, we analyzed a large lifespan sample of neuroimaging
data from 16,683 participants spanning nine decades of life starting at
birth. Results confirmed the hypothesis of greater male variability in
brain structure (Forde et al. 2020; Ritchie et al. 2018; Wierenga
et al. 2018, 2019). Variance differences were more pronounced for
subcortical volumes and regional cortical surface area than for
regional cortical thickness. We also corroborated prior findings of
greater male brain structural variance at both upper and lower tails of
brain measures (Wierenga et al. 2018). These variance effects seem to
describe a unique aspect of sex differences in the brain that does not
follow the regional pattern of mean sex differences. A novel finding
was that sex differences in variance appear stable across the lifespan
for around 50% of subcortical volumes, 70% of cortical surface area
measures and almost all cortical thickness measures. Unexpectedly,
regions with significant change in variance effects across the age
range showed decreasing variance differences between the sexes
with increasing age. Finally, we observed greater male inter-regional
homogeneity for cortical thickness, but not for surface area or
TABLE 2 (Continued)
(c) Thickness
Female (n = 6620) Male (n = 5913)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Right paracentral 0.004 -0.004 ** 0.055 0.065 **
Right parsopercularis 0.000 0.000 n.s. 0.001 0.037 **
Right parsorbitalis 0.018 -0.019 ** 0.164 0.026 n.s.
Right parstriangularis 0.004 -0.004 ** 0.053 0.008 **
Right pericalcarine 0.001 -0.001 n.s. 0.017 0.020 n.s.
Right postcentral 0.009 -0.009 ** 0.135 0.009 **
Right posteriorcingulate 0.007 -0.007 ** 0.082 0.013 **
Right precentral 0.008 -0.009 ** 0.119 0.084 **
Right precuneus -0.001 0.002 n.s. 0.018 0.063 **
Right rostralanteriorcingulate 0.009 -0.010 ** 0.080 0.055 n.s.
Right rostralmiddlefrontal 0.006 -0.006 ** 0.078 0.085 **
Right superiorfrontal 0.013 -0.013 ** 0.165 0.065 *
Right superiorparietal 0.008 -0.009 ** 0.132 0.065 **
Right superiortemporal -0.003 0.004 * 0.042 0.073 **
Right supramarginal 0.006 -0.007 ** 0.086 0.096 **
Right frontalpole 0.021 -0.022 ** 0.140 0.012 n.s.
Right temporalpole -0.006 0.007 * 0.038 0.023 n.s.
Right transversetemporal 0.011 -0.031 ** 0.095 0.101 *
Right insula -0.008 0.010 ** 0.107 0.092 **
* p < 0.05, ** p < 0.01, both after FDR correction.
F IGURE 2 Sex differences in variance ratio for subcortical volumes (Left), cortical surface area (center), and cortical thickness (right). Shown
are log transformed variance ratios, where significant larger variance ratio for males than females is displayed in blue ranging from 0 to 1. Darker
colors indicate a larger variance ratio
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subcortical volumes, partly replicating prior results of greater within-
subject homogeneity in the male brain (Wierenga et al. 2018). Unex-
pectedly, subcortical regions showed stronger interregional correla-
tion in females than in males.
Greater male variance was most pronounced in brain regions
involved in planning, regulation and inhibition of motor movements (pal-
lidum, right inferior parietal cortex and paracentral region), episodic
memory (hippocampus), and multimodal sensory integration (thalamus)
(Aron, Robbins, and Poldrack 2004; Burgess, Maguire, and O'Keefe
2002; Grillner et al. 2005). In addition, the early presence of sex differ-
ences in brain structural variability may be indicative of genetic effects,
in line with findings in a pediatric sample (Wierenga et al. 2018). We also
observed that sex differences in structural variation are either stable or
may reduce in old age. Longitudinal designs are, however, needed to
address the mechanisms underlying this observation.
The expression of greater male variability in both upper and lower
tails of the distribution may be related to architectural and geometric
constraints that are critical for a delicate balance for effective local-
global communication. For example, neurons only partly regulate their
size, and the number of neural connections does not vary strongly
with neocortical size across species (Stevens 1989). Although axon
size and myelin can compensate firing rates in larger brains by speed-
ing up conduction time, there is a limited energy budget to optimize
both volume and conduction time (Buzsáki, Logothetis, and
Singer 2013). As such, extreme brain structure (in both directions)
may come at a cost. This is in line with recent findings that show that
F IGURE 3 Jittered marginal distribution scatterplots are displayed together with their shift function for the top three variance ratio effects of
subcortical volumes (top), cortical surface area (middle) and cortical thickness (right). The central, darkest line on each distribution is the median,
note that main sex effects are removed. The other lines mark the deciles of each distribution. The shift values are included, which refer to the
number of units that the male (upper) distribution would have to be shifted to match the female (lower) distribution. Confidence intervals are
included for each of these shift values
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extreme neural activity patterns may induce suboptimal expressions
of mental states (Northoff and Tumati 2019). Interestingly, it has been
found that individuals with autism spectrum disorder show atypical
patterns of brain structure and development in both the upper and
lower range (Zabihi et al. 2019), suggesting a possible link between
greater male variability and vulnerability for developmental disorders
(see also Alnæs et al. 2019)). Together with our findings, this opens up
new approaches to understanding sex biased developmental disor-
ders, beyond group-level mean differences.
Although most results showed stable sex differences with
increasing age, half of the subcortical regions and a quarter of the cor-
tical surface area measures showed decreasing sex differences in vari-
ance. What stands out is that in all these regions, sex differences in
variance were largest in young compared to older age. This is indica-
tive of early mechanisms being involved. Furthermore, for subcortical
regions, the patterns showed larger volumetric increases in females
then in males. For surface area, interaction effects showed mostly sta-
ble variance across age in females, but decreases in variability in
males. The observation that there were no significant quadratic inter-
actions makes it unlikely that pubertal hormones may affect greater
male variance. Yet, the decrease in male variance in older age, may be
indicative of environmental effects later in life. Alternative explanation
may be the larger number of clinical or even death rates in males that
may lead to some sex difference in survival (Chen et al. 2008; Ryan
et al. 1997).
Factors underlying or influencing sex differences in the brain may
include sex chromosomes, sex steroids (both perinatal or pubertal),
and the neural embedding of social influences during the life span
(Dawson, Ashman, and Carver 2000). Although we could not directly
test these mechanisms, our findings of greater male variance, that are
mostly stable across age, together with the greater male inter-regional
homogeneity for cortical thickness are most in line with the single X-
chromosome expression in males compared to the mosaic pattern of
X-inactivation in females (Arnold 2012). Whereas female brain tissue
shows two variants of X-linked genes, males only show one. This
mechanism may lead to increased male vulnerability, as is also seen
for a number of rare X-linked genetic mutations (Chen et al. 2008;
Craig, Haworth, and Plomin 2009; Johnson, Carothers, and
Deary 2009; Reinhold and Engqvist 2013; Ryan et al. 1997). None of
the other sex effects mentioned above predict these specific inter and
intra-individual sex differences in brain patterns. Future studies are,
however, needed to directly test these different mechanisms. Further-
more, the observation that greater male homogeneity was only
observed in cortical thickness, but not cortical surface area or subcor-
tical volumes, may speculatively indicate that X-chromosome related
genetic mechanisms may have the largest effect on cortical thickness
measures.
This paper has several strengths including its sample size, the age
range spanning nine decades, the inclusion of different structural mea-
sures (subcortical volumes and cortical surface area and thickness)
and the investigation of variance effects. These points are important,
as most observed mean sex differences in the brain are modest in size
(Joel and Fausto-Sterling 2016). We were able to analyze data from a
far larger sample than those included in recent meta-analyses of mean
sex differences (Marwha et al. 2017; Ruigrok et al. 2014; Tan
et al. 2016), and a very wide age range covering childhood, adoles-
cence, adulthood and senescence. The results of this study may have
important implications for studies on mean sex differences in brain
structure, as analyses in such studies typically assume that group vari-
ances are equal, which the present study shows might not be tenable.
This can be particularly problematic for studies with small sample sizes
(Rousselet et al. 2017).
The current study has some limitations. First, the multi-site sam-
ple was heterogeneous and specific samples were recruited in differ-
ent ways, not always representative of the entire population.
Furthermore, although structural measures may be quite stable across
different scanners, the large number of sites may increase the vari-
ance in observed MRI measures, but this would be unlikely to be sys-
tematically biased with respect to age or sex. In addition, variance
effects may change in non-linear ways across the age-range. This may
F IGURE 4 Regions where sex differences in variability of brain structure interacted with age displayed for subcortical volumes (left), cortical
surface area (center), and cortical thickness (right)
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TABLE 3 Variance differences between sexes across age
(a) Subcortical Intercept SE p Age SE p Sex SE P Sex by age SE p
Left thal 587.987 6.178 ** 9398.523 652.185 ** 60.310 9.199 ** -3107.885 979.201 **
Right thal 515.416 5.524 ** 6424.232 583.119 ** 82.380 8.225 ** -3102.267 875.503 **
Left caud 361.790 3.729 ** 879.545 393.693 * 28.152 5.553 ** 270.769 591.096 n.s.
Right caud 371.773 3.785 ** 1290.352 399.567 ** 31.395 5.636 ** -561.719 599.915 n.s.
Left put 495.399 5.150 ** 4435.730 543.701 ** 54.586 7.669 ** -2966.533 816.321 **
Right put 460.842 4.887 ** 5622.177 515.939 ** 51.687 7.277 ** -3853.454 774.638 **
Left pal 165.039 1.816 ** 837.030 191.768 ** 26.852 2.705 ** -784.363 287.923 *
Right pal 140.799 1.598 ** 910.463 168.695 ** 26.247 2.379 ** -850.994 253.281 **
Left hippo 309.722 3.308 ** 2755.892 349.231 ** 31.626 4.926 ** -1375.500 524.341 *
Right hippo 305.607 3.264 ** 2615.969 344.571 ** 35.732 4.860 ** -890.970 517.345 n.s.
Left amyg 148.932 1.598 ** 1378.267 168.734 ** 13.800 2.380 ** -233.236 253.340 n.s.
Right amyg 154.218 1.645 ** 1621.298 173.675 ** 16.477 2.450 ** -540.141 260.758 n.s.
Left accumb 82.473 0.875 ** 442.922 92.410 ** 7.382 1.303 ** -136.472 138.746 n.s.
Right accumb 78.541 0.823 ** 539.975 86.850 ** 7.412 1.225 ** -106.522 130.398 n.s.
Surface area Intercept SE p Age SE p Sex SE p Sex by age SE p
Left bankssts 127.133 1.376 ** -437.616 142.554 ** 16.563 2.056 ** -574.105 219.785 *
Left caudalanteriorcingulate 104.209 1.113 ** -302.669 115.254 ** 4.299 1.663 ** -277.614 177.695 n.s.
Left caudalmiddlefrontal 293.750 2.943 ** -1359.284 304.791 ** 21.272 4.397 ** -660.300 469.918 n.s.
Left cuneus 154.129 1.607 ** -360.698 166.430 * 13.158 2.401 ** -330.457 256.596 n.s.
Left entorhinal 57.126 0.651 ** -458.398 67.397 ** 9.241 0.972 ** 1.893 103.911 n.s.
Left fusiform 305.090 3.105 ** 250.591 321.575 n.s. 35.738 4.639 ** -2446.584 495.794 **
Left inferiorparietal 454.916 4.708 ** -614.521 487.682 n.s. 63.459 7.035 ** -2243.805 751.894 *
Left inferiortemporal 352.394 3.540 ** -353.703 366.628 n.s. 31.482 5.289 ** -1652.239 565.256 *
Left isthmuscingulate 116.771 1.249 ** -32.188 129.411 n.s. 19.544 1.867 ** -204.545 199.522 n.s.
Left lateraloccipital 438.089 4.474 ** -1416.631 463.377 ** 50.571 6.685 ** -813.654 714.421 n.s.
Left lateralorbitofrontal 208.173 2.120 ** 204.108 219.597 n.s. 20.633 3.168 ** -1428.745 338.567 **
Left lingual 310.573 3.141 ** -234.334 325.364 n.s. 29.898 4.694 ** -1268.288 501.636 *
Left medialorbitofrontal 172.506 1.795 ** 3.188 185.938 n.s. 23.450 2.682 ** -213.946 286.673 n.s.
Left middletemporal 296.794 2.997 ** -421.492 310.480 n.s. 31.627 4.479 ** -1014.822 478.689 n.s.
Left parahippocampal 72.669 0.887 ** -211.577 91.839 * 10.825 1.325 ** -241.097 141.595 n.s.
Left paracentral 133.446 1.419 ** -195.857 147.019 n.s. 19.139 2.121 ** -171.708 226.670 n.s.
Left parsopercularis 193.582 2.113 ** -540.023 218.880 * 31.583 3.158 ** -459.911 337.462 n.s.
Left parsorbitalis 61.886 0.643 ** -172.940 66.566 ** 7.120 0.960 ** -131.612 102.629 n.s.
Left parstriangularis 148.566 1.524 ** -644.966 157.820 ** 19.173 2.277 ** -546.829 243.322 n.s.
Left pericalcarine 171.607 1.690 ** -245.127 175.004 n.s. 13.803 2.525 ** -283.583 269.815 n.s.
Left postcentral 340.927 3.572 ** -1033.492 370.007 ** 46.097 5.338 ** -1240.366 570.466 n.s.
Left posteriorcingulate 130.459 1.363 ** -176.189 141.217 n.s. 13.905 2.037 ** -400.954 217.724 n.s.
Left precentral 360.893 3.926 ** -1088.967 406.693 ** 47.580 5.867 ** -876.707 627.028 n.s.
Left precuneus 329.439 3.386 ** -444.670 350.720 n.s. 44.718 5.060 ** -1691.713 540.730 *
Left rostralanteriorcingulate 113.700 1.156 ** -6.807 119.754 n.s. 7.691 1.728 ** -80.447 184.632 n.s.
Left rostralmiddlefrontal 541.319 5.553 ** -1574.677 575.208 ** 63.888 8.298 ** -2391.074 886.838 *
Left superiorfrontal 577.465 6.015 ** -1306.494 623.063 * 75.007 8.988 ** -2320.740 960.620 n.s.
Left superiorparietal 471.735 4.793 ** -1198.240 496.487 * 57.076 7.162 ** -2051.708 765.468 *
Left superiortemporal 308.552 3.215 ** -864.236 333.037 ** 40.486 4.804 ** -1222.034 513.467 n.s.
Left supramarginal 392.296 4.082 ** -1937.799 422.787 ** 58.041 6.099 ** -775.470 651.841 n.s.
Left frontalpole 25.431 0.265 ** -114.432 27.425 ** 3.212 0.396 ** -7.992 42.283 n.s.
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TABLE 3 (Continued)
Surface area Intercept SE p Age SE p Sex SE p Sex by age SE p
Left temporalpole 45.410 0.478 ** -173.235 49.555 ** 5.115 0.715 ** -59.323 76.403 n.s.
Left transversetemporal 56.992 0.594 ** -201.824 61.535 ** 6.690 0.888 ** -81.655 94.872 n.s.
Left insula 164.339 1.842 ** -460.767 190.830 * 17.215 2.753 ** 6.824 294.215 n.s.
Right bankssts 107.290 1.139 ** -392.600 117.986 ** 13.575 1.702 ** -493.453 181.908 *
Right caudalanteriorcingulate 114.549 1.199 ** -266.524 124.192 * 14.948 1.792 ** -8.218 191.475 n.s.
Right caudalmiddlefrontal 288.671 2.929 ** -1415.348 303.395 ** 30.576 4.377 ** -360.883 467.765 n.s.
Right cuneus 152.647 1.656 ** -146.322 171.565 n.s. 16.151 2.475 ** -436.462 264.513 n.s.
Right entorhinal 57.865 0.641 ** -455.979 66.351 ** 10.302 0.957 ** -50.231 102.298 n.s.
Right fusiform 295.259 3.000 ** 43.695 310.723 n.s. 32.408 4.483 ** -1812.528 479.064 **
Right inferiorparietal 504.767 5.239 ** -577.142 542.646 n.s. 82.015 7.828 ** -2767.949 836.635 **
Right inferiortemporal 327.236 3.331 ** -482.481 345.043 n.s. 28.512 4.978 ** -1116.568 531.977 n.s.
Right isthmuscingulate 105.700 1.157 ** -228.263 119.818 n.s. 16.311 1.729 ** -192.830 184.732 n.s.
Right lateraloccipital 436.925 4.537 ** -1283.916 469.975 ** 58.726 6.780 ** -1927.057 724.593 *
Right lateralorbitofrontal 220.527 2.284 ** 236.472 236.616 n.s. 24.442 3.413 ** -1470.759 364.808 **
Right lingual 289.568 3.001 ** -299.806 310.855 n.s. 34.596 4.484 ** -1128.138 479.266 n.s.
Right medialorbitofrontal 154.743 1.568 ** 74.312 162.424 n.s. 15.452 2.343 ** -964.430 250.420 **
Right middletemporal 309.733 3.171 ** -517.078 328.408 n.s. 34.194 4.738 ** -1188.068 506.329 n.s.
Right parahippocampal 70.171 0.781 ** -155.100 80.940 n.s. 11.822 1.168 ** -420.498 124.790 **
Right paracentral 156.024 1.669 ** -273.907 172.868 n.s. 25.570 2.494 ** -271.297 266.523 n.s.
Right parsopercularis 174.570 1.866 ** -1036.595 193.296 ** 25.454 2.789 ** -231.029 298.018 n.s.
Right parsorbitalis 77.607 0.794 ** -103.424 82.287 n.s. 7.160 1.187 ** -311.879 126.867 *
Right parstriangularis 184.989 1.887 ** -925.697 195.494 ** 21.344 2.820 ** -662.628 301.407 n.s.
Right pericalcarine 184.490 1.818 ** -314.748 188.350 n.s. 13.276 2.717 ** -264.356 290.392 n.s.
Right postcentral 330.886 3.494 ** -1175.639 361.875 ** 44.061 5.220 ** -907.204 557.928 n.s.
Right posteriorcingulate 133.953 1.413 ** 42.583 146.371 n.s. 14.739 2.112 ** -695.150 225.670 *
Right precentral 374.619 4.131 ** -1039.063 427.849 * 53.576 6.172 ** -579.997 659.645 n.s.
Right precuneus 355.783 3.685 ** -894.373 381.705 * 42.292 5.507 ** -1788.652 588.501 *
Right rostralanteriorcingulate 97.009 1.005 ** 198.486 104.078 n.s. 10.668 1.501 ** -140.756 160.464 n.s.
Right rostralmiddlefrontal 560.924 5.691 ** -2015.333 589.514 ** 60.682 8.504 ** -1467.830 908.895 n.s.
Right superiorfrontal 586.059 6.054 ** -748.583 627.121 n.s. 72.274 9.047 ** -3613.685 966.876 **
Right superiorparietal 453.081 4.716 ** -1983.725 488.528 ** 49.530 7.048 ** 42.170 753.197 n.s.
Right superiortemporal 281.023 2.898 ** -481.481 300.133 n.s. 31.844 4.330 ** -1005.995 462.736 n.s.
Right supramarginal 376.538 3.839 ** -1315.029 397.627 ** 51.001 5.736 ** -1362.209 613.049 n.s.
Right frontalpole 34.322 0.352 ** -93.541 36.451 * 2.974 0.526 ** -112.046 56.199 n.s.
Right temporalpole 44.173 0.457 ** -144.791 47.330 ** 5.067 0.683 ** -32.370 72.972 n.s.
Right transversetemporal 43.342 0.436 ** -122.601 45.112 ** 4.348 0.651 ** -76.872 69.553 n.s.
Right insula 185.386 1.947 ** 167.564 201.684 n.s. 22.970 2.910 ** -270.419 310.950 n.s.
Thickness Intercept SE p Age SE p Sex SE p Sex by age SE p
Left bankssts 0.138 0.001 ** 0.012 0.150 n.s. 0.002 0.002 n.s. 0.345 0.217 n.s.
Left caudalanteriorcingulate 0.204 0.002 ** 1.405 0.217 ** -0.005 0.003 n.s. 0.207 0.314 n.s.
Left caudalmiddlefrontal 0.119 0.001 ** 0.375 0.131 ** 0.002 0.002 n.s. -0.108 0.190 n.s.
Left cuneus 0.108 0.001 ** -0.194 0.118 n.s. 0.003 0.002 n.s. -0.386 0.171 n.s.
Left entorhinal 0.263 0.003 ** 0.348 0.288 n.s. 0.001 0.004 n.s. -0.414 0.417 n.s.
Left fusiform 0.114 0.001 ** 0.484 0.125 ** 0.000 0.002 n.s. -0.340 0.181 n.s.
Left inferiorparietal 0.109 0.001 ** 0.329 0.122 ** 0.005 0.002 ** 0.023 0.176 n.s.
Left inferiortemporal 0.128 0.001 ** 0.515 0.138 ** 0.000 0.002 n.s. -0.327 0.199 n.s.
(Continues)
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TABLE 3 (Continued)
Thickness Intercept SE p Age SE p Sex SE p Sex by age SE p
Left isthmuscingulate 0.165 0.002 ** 0.491 0.175 ** -0.003 0.002 n.s. -0.076 0.254 n.s.
Left lateraloccipital 0.096 0.001 ** 0.132 0.106 n.s. 0.004 0.001 ** 0.057 0.154 n.s.
Left lateralorbitofrontal 0.124 0.001 ** 0.212 0.138 n.s. 0.006 0.002 ** -0.438 0.201 n.s.
Left lingual 0.099 0.001 ** 0.343 0.109 ** 0.001 0.001 n.s. -0.308 0.157 n.s.
Left medialorbitofrontal 0.135 0.001 ** 0.067 0.150 n.s. 0.004 0.002 n.s. -0.425 0.217 n.s.
Left middletemporal 0.129 0.001 ** 0.493 0.140 ** 0.004 0.002 * -0.012 0.203 n.s.
Left parahippocampal 0.248 0.002 ** 0.441 0.254 n.s. 0.002 0.003 n.s. -0.372 0.368 n.s.
Left paracentral 0.126 0.001 ** 0.321 0.138 * 0.003 0.002 n.s. -0.017 0.199 n.s.
Left parsopercularis 0.123 0.001 ** 0.497 0.134 ** 0.005 0.002 ** -0.358 0.194 n.s.
Left parsorbitalis 0.178 0.002 ** -0.413 0.192 * 0.004 0.003 n.s. 0.266 0.278 n.s.
Left parstriangularis 0.134 0.001 ** 0.145 0.144 n.s. 0.004 0.002 * -0.073 0.209 n.s.
Left pericalcarine 0.101 0.001 ** 0.202 0.114 n.s. 0.001 0.002 n.s. -0.325 0.165 n.s.
Left postcentral 0.097 0.001 ** 0.340 0.106 ** 0.004 0.001 ** 0.222 0.154 n.s.
Left posteriorcingulate 0.131 0.001 ** 0.308 0.142 * 0.005 0.002 ** -0.236 0.205 n.s.
Left precentral 0.110 0.001 ** 1.223 0.122 ** 0.004 0.002 * 0.181 0.177 n.s.
Left precuneus 0.111 0.001 ** 0.521 0.121 ** 0.003 0.002 n.s. -0.056 0.176 n.s.
Left rostralanteriorcingulate 0.193 0.002 ** 0.470 0.205 * -0.005 0.003 n.s. -0.378 0.298 n.s.
Left rostralmiddlefrontal 0.109 0.001 ** 0.153 0.122 n.s. 0.005 0.002 ** 0.039 0.177 n.s.
Left superiorfrontal 0.124 0.001 ** 0.505 0.137 ** 0.002 0.002 n.s. 0.083 0.198 n.s.
Left superiorparietal 0.099 0.001 ** 0.158 0.109 n.s. 0.004 0.001 ** 0.224 0.158 n.s.
Left superiortemporal 0.129 0.001 ** 0.832 0.139 ** 0.004 0.002 * -0.123 0.201 n.s.
Left supramarginal 0.114 0.001 ** 0.396 0.122 ** 0.005 0.002 ** 0.063 0.177 n.s.
Left frontalpole 0.241 0.002 ** -1.236 0.266 ** 0.004 0.004 n.s. 0.112 0.386 n.s.
Left temporalpole 0.268 0.003 ** -2.010 0.301 ** 0.006 0.004 n.s. -0.518 0.436 n.s.
Left transversetemporal 0.182 0.002 ** 0.027 0.194 n.s. -0.001 0.003 n.s. -0.168 0.281 n.s.
Left insula 0.125 0.001 ** 1.184 0.135 ** 0.002 0.002 n.s. -0.700 0.195 *
Right bankssts 0.146 0.001 ** -0.094 0.157 n.s. 0.003 0.002 n.s. 0.217 0.228 n.s.
Right caudalanteriorcingulate 0.186 0.002 ** 0.936 0.198 ** -0.008 0.003 ** -0.105 0.288 n.s.
Right caudalmiddlefrontal 0.120 0.001 ** 0.226 0.130 n.s. 0.002 0.002 n.s. 0.179 0.189 n.s.
Right cuneus 0.110 0.001 ** 0.037 0.118 n.s. 0.001 0.002 n.s. -0.334 0.170 n.s.
Right entorhinal 0.288 0.003 ** 0.122 0.310 n.s. 0.004 0.004 n.s. -0.746 0.449 n.s.
Right fusiform 0.114 0.001 ** 0.657 0.125 ** 0.001 0.002 n.s. -0.171 0.181 n.s.
Right inferiorparietal 0.109 0.001 ** 0.390 0.120 ** 0.005 0.002 ** 0.233 0.174 n.s.
Right inferiortemporal 0.124 0.001 ** 0.539 0.135 ** 0.003 0.002 n.s. -0.132 0.196 n.s.
Right isthmuscingulate 0.162 0.002 ** 0.401 0.172 * -0.002 0.002 n.s. 0.223 0.249 n.s.
Right lateraloccipital 0.101 0.001 ** 0.280 0.110 * 0.005 0.001 ** 0.023 0.159 n.s.
Right lateralorbitofrontal 0.129 0.001 ** -0.174 0.144 n.s. 0.004 0.002 * -0.110 0.208 n.s.
Right lingual 0.102 0.001 ** 0.172 0.111 n.s. 0.000 0.002 n.s. -0.201 0.161 n.s.
Right medialorbitofrontal 0.142 0.001 ** -0.424 0.156 ** 0.003 0.002 n.s. -0.201 0.227 n.s.
Right middletemporal 0.123 0.001 ** 0.067 0.137 n.s. 0.006 0.002 ** 0.400 0.198 n.s.
Right parahippocampal 0.207 0.002 ** 0.554 0.224 * 0.005 0.003 n.s. -0.115 0.325 n.s.
Right paracentral 0.124 0.001 ** 0.492 0.134 ** 0.002 0.002 n.s. -0.050 0.194 n.s.
Right parsopercularis 0.131 0.001 ** 0.330 0.139 * 0.001 0.002 n.s. -0.056 0.201 n.s.
Right parsorbitalis 0.175 0.002 ** -0.470 0.188 * 0.002 0.003 n.s. 0.159 0.273 n.s.
Right parstriangularis 0.131 0.001 ** -0.016 0.141 n.s. 0.002 0.002 n.s. 0.052 0.204 n.s.
Right pericalcarine 0.102 0.001 ** 0.199 0.112 n.s. 0.002 0.002 n.s. -0.336 0.163 n.s.
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be particularly apparent for surface area and subcortical volume mea-
sures, as these showed pronounced non-linear developmental pat-
terns through childhood and adolescence (Tamnes et al. 2017;
Wierenga et al. 2018). Also, the imbalanced number of subjects across
the age range may have diminished variability effects in the older part
of the age range. The present study has a cross-sectional design.
Future studies including longitudinal data are warranted to further
explore the lifespan dynamics of sex differences in variability in the
brain. Last, one caveat may be the effect of movement on data quality
and morphometric measures. As males have been shown to move
more than females in the scanner (Pardoe, Kucharsky Hiess, and
Kuzniecky 2016), this may have resulted in slight under estimations of
brain volume and thickness measures for males (Reuter et al. 2015).
Although quality control was conducted at each site using the stan-
dardized ENIGMA cortical and subcortical quality control protocols
(http://enigma.ini.usc.edu/protocols/imaging-protocols/), which
involve a combination of statistical outlier detection and visual quality
checks and a similar number of males and females had partially miss-
ing data (52.4% males), we cannot exclude the possibility that in-
scanner subject movement may have affected the results. Neverthe-
less, we do not think this can explain our finding of greater male vari-
ance in brain morphometry measures, as this was seen at both the
upper and lower ends of the distributions.
5 | CONCLUSIONS
The present study included a large lifespan sample and robustly con-
firmed previous findings of greater male variance in brain structure in
humans. We found greater male variance in all brain measures, includ-
ing subcortical volumes and regional cortical surface area and thick-
ness, at both the upper and the lower end of the distributions. The
results have important implications for the interpretation of studies
on (mean) sex differences in brain structure. Furthermore, the results
of decreasing sex differences in variance across age opens a new
direction for research focusing on lifespan changes in variability within
sexes. Our findings of sex differences in regional brain structure being
present already in childhood may suggest early genetic or gene-
environment interaction mechanisms. Further insights into the ontog-
eny and causes of variability differences in the brain may provide
clues for understanding male biased neurodevelopmental disorders.
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F IGURE 6 (a–c) Stronger anatomical correlations for males than females are indicated in blue (larger homogeneity in males than females),
while stronger correlations for females are displayed in red (larger homogeneity in females than males). The bottom left half shows the significant
variance ratio's only, using two sided permutation testing. Results are displayed for subcortical volumes (a), surface area (b), and cortical thickness
(c). Cortical regions are ordered by lobe and hemisphere (left frontal, left occipital, left parietal, left temporal, right frontal, right occipital, right
parietal, right temporal)
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